The effectiveness of the anti-tumor necrosis factor therapy infliximab in neuro-Behçet's disease: a systematic review and meta-analysis.

J Int Med Res · 2023 · PMC10201531 · PMID 37203384

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

An increasing trend of effectiveness was observed over the previous two decades, which may be due to improved accuracy in diagnosing neuro-Behçet’s disease, increasing confidence in the use of anti-TNF biologics, and the recent adoption of a treat-to-target strategy in the management of autoimmune rheumatic diseases.

also in 25,605 other papers

possibly significantno p-value reported

In terms of treatment effect measures, outcome data, assessed as early as 4–12 weeks, were extracted regarding changes in neurological disease and MRI lesions with/without other possibly significant disease-related markers and/or CSF analysis.

also in 143 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.